I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023

IMAB Stock  USD 0.98  0.05  5.38%   
About 55% of I Mab's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding I Mab suggests that some traders are interested. The current market sentiment, together with I Mab's historical and current headlines, can help investors time the market. In addition, many technical investors use I Mab stock news signals to limit their universe of possible portfolio assets.
  
I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023 Published Mar. 20, 2023 at 200 AM HST Updated 17 minutes ago GAITHERSBURG, Md. and SHANGHAI, China , March 20, 2023 PRNewswire -- I-Mab the Compa

Read at hawaiinewsnow.com
news
  

I Mab Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards I Mab can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

I Mab Fundamental Analysis

We analyze I Mab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of I Mab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of I Mab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Operating Margin

Operating Margin Comparative Analysis

I Mab is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

I Mab Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with I Mab stock to make a market-neutral strategy. Peer analysis of I Mab could also be used in its relative valuation, which is a method of valuing I Mab by comparing valuation metrics with similar companies.

Peers

I Mab Related Equities

ERASErasca   12.94   
0%
100.0%
LYELLyell Immunopharma   5.26   
0%
40.0%
DSGNDesign Therapeutics   4.67   
0%
36.0%
APLSApellis Pharmaceuticals   4.39   
0%
33.0%
IMVTImmunovant   2.09   
0%
16.0%
KYMRKymera Therapeutics   1.90   
0%
14.0%
BPMCBlueprint Medicines   1.29   
0%
9.0%
FHTXFoghorn Therapeutics   0.50   
0%
3.0%
AKROAkero Therapeutics   0.28   
2.0%
0%
STTKShattuck Labs   0.91   
7.0%
0%
KRYSKrystal Biotech   1.27   
9.0%
0%
GLUEMonte Rosa   1.35   
10.0%
0%
ASNDAscendis Pharma   1.89   
14.0%
0%
CGEMCullinan Oncology   2.08   
16.0%
0%
NRIXNurix Therapeutics   2.80   
21.0%
0%
BGNEBeiGene   4.30   
33.0%
0%
RVMDRevolution Medicines   10.46   
80.0%
0%

Complementary Tools for IMAB Stock analysis

When running I Mab's price analysis, check to measure I Mab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Mab is operating at the current time. Most of I Mab's value examination focuses on studying past and present price action to predict the probability of I Mab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Mab's price. Additionally, you may evaluate how the addition of I Mab to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account